Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders

Everest Medicines Acquires Exclusive Rights to Novel Biologic for Eye Disorders Everest Medicines has acquired an exclusive license to develop and commercialize VIS-101, a novel bifunction…